Molecular Templates Strengthens Board of Directors and Management Team
AUSTIN, Texas, March 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or “the Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), today announced the appointment of Gabriela Gruia, M.D., to its Board of Directors and the promotion of Megan Filoon to General Counsel.
- Dr. Gruia brings a wealth of industry knowledge to our Board of Directors, said Barry Selick, Ph.D., Chairman of the Board of Molecular Templates.
- Dr. Gruia stated, I am pleased to have the opportunity to join the Molecular Templates Board of Directors.
- Megan Filoon joined Molecular Templates in May 2018 as Corporate Counsel and most recently served as Vice President, Legal.
- Megans diverse and extensive legal expertise and her track record of success make her a great addition to the MTEM senior management team, said Eric Poma, CEO and CSO of Molecular Templates.